SERA-SCANDIA A/S: Financial statements 2025
CVR: 14605185
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
SERA-SCANDIA A/S (CVR 14605185) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 40,586,000 and a net result of DKK -7,801,000 compared with DKK 2,203,000 the year before. That is an increase of 9.9% compared with the year before. Equity in the 2025 report amounted to DKK 272,104,000. The solvency ratio was 62.5%. The company had 226 employees in the financial year.
- Gross Profit
- DKK 40,586,000
- Profit/Loss
- DKK -7,801,000
- Equity
- DKK 272,104,000
- Total Assets
- DKK 435,283,000
- Employees
- 226
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 40.6M | -7.8M | 272.1M | 226 |
| 2024 | - | 36.9M | 2.2M | 295.7M | 231 |
| 2023 | - | 41.9M | 3M | 291.4M | 273 |
| 2022 | - | 46.9M | 11.4M | 83.1M | 274 |
| 2021 | 242.3M | 28.7M | 16.1M | 62M | 176 |
Official annual report
How creditworthy is SERA-SCANDIA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of October 1, 2025, Troels Zakarias Glahn Kristiansen is registered as adm. dir. of SERA-SCANDIA A/S.
As of October 1, 2025, Stefan Bødtker Michelsen has stepped down as director of SERA-SCANDIA A/S.
SERA-SCANDIA A/S has published its annual report for 2024. Gross profit came to DKK 36,945,000, and the net result was DKK 2,203,000.
As of June 19, 2025, Christian Lykkehus Sørensen has joined the board of directors of SERA-SCANDIA A/S.
As of May 15, 2025, Stefan Bødtker Michelsen has left the board of directors of SERA-SCANDIA A/S.
About SERA-SCANDIA A/S
SERA-SCANDIA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1990. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SERA-SCANDIA ApS and VICH 2604 ApS. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Christian Lykkehus Sørensen and Nicolas Bødtker Nielsen. The company is owned by Danbiotech Inc.. The company has 16 employees (2026). In 2025, the company reported a gross profit of DKK 40,586,000 and a net result of DKK -7,801,000 compared with DKK 2,203,000 the year before. Equity in the 2025 report amounted to DKK 272,104,000.
